the efficacy and safety of nadolol and atenolol , 2 new long-acting beta-adrenergic receptor antagonists , were evaluated in patients with recurrent supraventricular tachycardia ( svt ) .
C0004147
atenolol
C0039240
supraventricular tachycardia